echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The State Drug Administration issued an announcement on the revision of the instructions for the injection of birdine in mendionine

    The State Drug Administration issued an announcement on the revision of the instructions for the injection of birdine in mendionine

    • Last Update: 2020-11-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The specific announcement is as follows: The State Drug Administration's announcement on the revision of the instructions for the injection of mentamate birdine (No. 121 of 2020) In order to further ensure the safety of public drug use, the State Drug Administration has decided to inject mentamate birdine (including The instructions "Adverse reactions", "precautions", "taboos", "pregnant and lactating women's medication", "children's medicine" and "old age medication" are revised.
    The relevant matters will now be announced as follows: First, all production enterprises of methionine birdine injections shall, in accordance with the Measures for the Administration of Drug Registration and other relevant provisions, in accordance with the revised requirements of the instructions for the injection of methionine (see annex), put forward a supplementary application for revision of the instructions, to be reported to the provincial drug regulatory authorities before January 28, 2021 for the record.
    the contents of the drug shall be revised together, and the instructions and other contents of the label shall be consistent with the original approval contents.
    to replace all factory-issued drug instructions and labels within 9 months of filing the supplementary application.
    The above-mentioned production enterprises for the occurrence of new adverse reactions should carry out in-depth research on the mechanism of new adverse reactions, take effective measures to do a good job in the use and safety of publicity and training, related to drug safety content changes should immediately and appropriately notify the drug management and use units, guide physicians, pharmacists reasonable drug use.
    . Clinicians and pharmacists shall carefully read the revised contents of the instruction manual for the injection of methionine and, when selecting the drug, conduct a full benefit/risk analysis in accordance with the newly revised instruction manual.
    , patients should strictly follow the doctor's instructions for medication, before taking the drug should carefully read the instructions.
    this announcement.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.